Trend Watch

Trend Watch

News you can use for your patients and practice.

Trend WatchPerspective

FDA Approves DAAs for Pediatric Patients with HCV

HCV Next, April
The FDA has approved sofosbuvir and ledipasvir/sofosbuvir as supplemental applications for the treatment of hepatitis C in children aged 12 to 17…
Trend Watch

PCORI Awards $29.5 Million for HCV; $14 Million for PWID Research

HCV Next, January 2016
The Patient-Centered Outcomes Research Institute board of governors announced it has approved two grants worth $29.5 million to fund two…
Trend Watch

FDA Accepts NDA for Review of 3D Regimen

HCV Next, January 2016
AbbVie announced that the FDA has accepted its New Drug Application for review of ombitasvir, paritaprevir and ritonavir tablets with dasabuvir…
Trend Watch

FDA Updates Labeling for Simeprevir

HCV Next, December 2015
The FDA recently announced revisions to product labeling for simeprevir used in combination with ribavirin and peginterferon alfa for the treatment…
Trend Watch

FDA Grants Priority Review, NICE Recommends Daclatasvir

HCV Next, December 2015
Bristol-Myers Squibb announced the FDA accepted the company’s three supplemental New Drug Applications for review of daclatasvir in combination…
Trend Watch

New App Allows Patients with HCV to Track Their Health

HCV Next, November 2015
Boston Children’s Hospital and Boston Children’s Computational Health Informatics Program have developed an iPhone application that…
Trend Watch

FDA Issues Warning, AbbVie Explains Label Changes for HCV Drugs

HCV Next, November 2015
The FDA released a statement warning of serious liver injury caused by the hepatitis C virus treatments ombitasvir/paritaprevir/ritonavir plus…
Trend Watch

European Commission Approves 12 Weeks of Daclatasvir/Sofosbuvir for HCV Genotype 3

HCV Next, October 2015
Bristol-Myers Squibb announced the European Commission has approved an updated label for daclatasvir to be used in combination with sofosbuvir for…
Trend Watch

One in Four Patients with HCV Denied Initial Request for Treatment

HCV Next, October 2015
A new study published in PLoS ONE showed that one in four patients with hepatitis C virus infection who apply for treatment of the infection is…
Trend Watch

WHO Encourages Safe Injection Use to Prevent HBV, HCV

HCV Next, September 2015
In honor of the fifth annual World Hepatitis Day on July 28, 2015, the World Health Organization has launched a pilot, global safety injection…